By Dr. Brandon Bright, DAOM, LAc · Doctor of Acupuncture & Oriental Medicine · Functional Medicine University-certified · Clinical Hypnotherapist · Founder, Quantum Mind · Tustin, CA · Last reviewed: June 13, 2026
We launched the Quantum Mind beta on Monday, June 1, 2026. As of this writing, we’re 13 days in. This is the kind of post that ought to be uncomfortable for a founder to publish, which is why I’m publishing it: an honest review of what’s working, what’s still rough, and where the architectural choices are landing in real-world use. If you’re considering joining the beta, this should help you decide whether the current state of the app fits what you actually need.
Disclosure First
I founded Quantum Mind. This is a founder review of our own product. That makes me the wrong person to write the definitive third-party review, and the right person to write a transparent inside view. The way I’m managing the conflict: I’m telling you what’s working, what’s not, what’s surprised us, and what we’re going to do about each rough edge. I’m not going to compare us favorably against competitors who don’t have a chance to respond. Where it’s fair to name the architectural tradeoffs against Hypnothera and Reveri, I do — but I link out to my earlier piece that goes deeper rather than relitigating it here.
If a comparison from a category founder isn’t useful to you, that’s a reasonable read. Stop here, see the Reveri Stanford study (n=84,395 — best published outcome data in the category), and make your decision from there. If you want the inside view, read on.
What Quantum Mind Is, in One Paragraph
Quantum Mind generates a custom hypnotherapy session for you each time you use it. The session content is built around your specific cognitive style, language patterns, and recent progress — not selected from a library and adapted. Each session blends clinical hypnotherapy with Neuro-Linguistic Programming (NLP) techniques (anchoring, swish, parts integration, reframing) in the same session. The flagship use cases at launch: sleep, anxiety, ADHD focus, perimenopausal vasomotor symptoms, smoking cessation, and executive performance. The deeper architectural rationale is laid out in my earlier piece on why we generate sessions fresh every time.
What’s Working in Beta Week 1-2
I want to lead with what’s working, then walk through what’s still rough.
Metaphor matching is delivering on the architectural bet. The first signal we look at is whether the imagery our AI generates resonates with users on the first listen. Across our early beta cohort, the “felt like it was written for me” response is showing up at a meaningfully higher rate than what library-based apps report. That’s the architecture doing what it was designed to do — generating imagery that matches your cognitive style rather than deploying universal metaphors adaptively. Sleep onset users are reporting they’re falling asleep mid-session more often than they expected; that’s the language landing in the right places.
The NLP integration is reaching users it was built for. ADHD focus and habit-change use cases are showing the strongest week-1 retention. We theorized this — NLP techniques (especially anchoring and swish patterns) are where the integrated approach has the cleanest mechanism — and the data is bearing that out. Users who came in for sleep alone are also asking for focus sessions after 3-4 days, which we didn’t expect to see this early.
The DAOM clinical pipeline is engaging Orange County users. A meaningful slice of the OC waitlist is asking about layering app + in-person work at the Tustin clinic. That’s the multi-modality wedge we built — and it’s confirming the hypothesis that local users want the integration, not just the app.
Onboarding flow is converting cleanly. The 90-day complimentary period removes the friction it was designed to remove. Beta users are exploring use cases they wouldn’t have paid for first. That’s giving us real signal on which niches matter most to real people, which is exactly what beta is for.
What’s Still Rough
Generation latency is real. I told you in the architectural piece that Quantum Mind takes longer than Hypnothera’s 60-second generation because the per-user content generation is doing different upstream work. In practice, the first-session latency for a brand-new user is longer than I’m comfortable with. Returning users hit cached metaphor profiles and the latency drops, but the first-session experience needs to feel snappier. We have an optimization queued for week 3-4 that should cut the first-session generation time meaningfully without sacrificing the per-user metaphor matching. I’ll report on whether we hit the target in the week 4 update.
The onboarding intake is asking the right questions but in the wrong order. We learned this from user behavior — the cognitive-style-mapping section sits where the high-friction goal-mapping section should sit, and we’re losing some users to drop-off before the AI has enough context to do its best work. Fix is queued for next release.
Voice variety is more limited than we want. We launched with three voice options; users are asking for more, and specifically for voice-tone matching to the metaphor family they responded to in the intake. That’s a meaningful product gap and we’re prioritizing it.
Menopause vasomotor symptom protocol needs deeper customization. Perimenopausal beta users are coming in with more nuanced needs than our launch session structure handles well. Hot-flash management has a real autonomic-regulation mechanism through hypnotherapy (the Mayo Clinic studies on hypnotic relaxation for hot flashes are well documented). We launched a session framework that works for many but is too generic for the women coming in mid-pattern. Refining now.
Cross-session memory is shallower than the architecture eventually supports. Right now, the AI remembers your metaphor profile and your goals across sessions but doesn’t yet weight recent session content into the next session’s structure. That’s the next major upgrade. The current state is good; the eventual state is what justifies the architecture choice.
What Surprised Us
ADHD focus retention. I expected sleep to be the highest-retention use case in week 1. It wasn’t. ADHD focus pulled ahead by a clear margin, which I now think reflects how undersupplied the category has been — most AI hypnosis apps don’t carry NLP anchoring techniques, and the focus crowd has been actively looking for tools that go beyond meditation app territory.
The cognitive-style mapping is more diagnostic than we built it to be. Several users have written in saying that the intake itself surfaced patterns they hadn’t articulated before. That wasn’t the design goal; the intake exists to inform session generation. The fact that users are getting standalone value from the intake suggests we have more room to design here.
Local + app integration is a real category. I expected most beta users to be remote (US-wide, app-only). The OC slice asking about in-person integration is bigger than I projected. That changes how we think about expansion — clinical-pipeline integration may matter more than we modeled.
Reveri and Hypnothera traffic patterns we can see indirectly. A meaningful chunk of beta users came in having tried Reveri or Hypnothera and looked for something deeper. That tells us the architectural wedge (per-user generation + NLP integration) is legible to the category’s existing audience, which I wasn’t sure we’d see this early.
What’s Next (Week 3-4 Roadmap)
In rough priority order: generation latency optimization, onboarding intake re-ordering, voice-tone matching expansion, menopause protocol customization deepening, cross-session memory weighting. We’ll have a week-4 update piece around June 27 with what shipped and what landed.
Should You Join the Beta Now or Wait?
Join now if you want focus/ADHD work, sleep onset, anxiety regulation, or smoking cessation, and you’re willing to be an early-architecture user. The 90-day complimentary period means you can try multiple use cases without paying for the experimentation phase. We’re absorbing the rough edges and shipping fast — week-3 release should land before the end of June.
Wait if your use case is perimenopausal vasomotor symptom management as your primary need. The customization there is in active improvement. End of June should be a better entry point for that specific niche.
Look elsewhere if you need the largest published clinical outcome study (Reveri is the right answer there), the lowest price point ($89/year Reveri or credit-tier Hypnothera both sit below our projected post-beta pricing), or fast situational scripts in under 60 seconds (Hypnothera is built for that).
How to Join
Join the Quantum Mind beta waitlist — 90-day complimentary period for current waitlist members. After beta, projected pricing is $25-$45/month depending on tier.
Frequently Asked Questions
Is Quantum Mind a medical device or a clinical tool? Neither. It’s a self-paced AI hypnotherapy app for sleep, anxiety, focus, smoking, perimenopausal support, and performance. It’s not FDA-cleared and doesn’t carry medical-device claims. For clinical hypnotherapy with a licensed clinician, in-person work at the Tustin practice is the right path — and many Orange County users layer both.
How long is the beta? Through approximately end of August 2026. Beta waitlist members keep the 90-day complimentary period through post-beta transition.
Can I cancel during the complimentary period? Yes, anytime, no charge.
Will the post-beta pricing definitely be $25-$45/month? Projected. Final pricing locked closer to commercial launch.
Does Quantum Mind work outside California? Yes — the app is US-wide. The clinical integration with the Tustin practice is for California patients only (DAOM/LAc license scope).
I tried Reveri and didn’t love it — is Quantum Mind different enough to be worth trying? Probably. The metaphor-matching architecture works on a different mechanism than Reveri’s library-deployment model. Different users respond to different architectures. The complimentary beta makes it low-risk to find out.
Are you taking comments from beta users seriously? Yes. The roadmap above is built from week-1 user signal. If you join and you have feedback, the in-app feedback is going directly to the product team (me and three engineers). We respond.
Is there a clinical version with prescriptions? No. Quantum Mind doesn’t prescribe. Prescriptions in California come from licensed prescribers; the in-person Tustin practice operates within DAOM/LAc scope (acupuncture, hypnotherapy, functional medicine consultation, peptide therapy guidance, herbal formulas). Different role, different tool.
What to Do This Week
If you want the deeper-personalization AI hypnotherapy architecture and you want it now: join the Quantum Mind beta. 90-day complimentary period.
If you’re in Orange County and you want the clinical hypnotherapy in-person layer the app integrates with: book a first visit at the Tustin practice. $199 in-person initial, $150 virtual.
If you want a more architectural deep-dive on why we generate fresh sessions every time instead of deploying a library: read the architecture piece.
Dr. Brandon Bright, DAOM, LAc
Holistic and integrative medicine practitioner serving Tustin and patients nationwide.